Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome

Clinical trial NCT07270549 · RECRUITING

Trial details

NCT number: NCT07270549
Sponsor: CTNNB1 Foundation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

CTNNB1 Neurodevelopmental Syndrome

Start date: 2025-11-01
Primary completion: 2032-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.